A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis

NCT07533955 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhematoid Arthritis

Interventions

DRUG: JADE201
DRUG: Placebo

Sponsor

Jade Biosciences, Inc.